Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eisai
Company Monitoring Page for Eisai
latest headlines for company on cafepharma
Pharmaceutical Giant Eisai Hit By Ransomware Incident
Infosecurity Magazine
Sun, 06/11/23 - 11:09 pm
Tags:
Eisai
,
cyberattack
,
ransomware
Eisai files Leqembi in Korea, as US prospects firm up
Pharmaphorum
Thu, 06/8/23 - 10:02 am
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
,
South Korea
,
Asia
Ahead of key meeting, FDA appears open to full approval of Alzheimer’s drug Leqembi
BioPharma Dive
Wed, 06/7/23 - 09:53 pm
Tags:
FDA
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
Alzheimer’s Drug Market To Hit $13 Billion As FDA Approvals And Insurance Coverage Escalate
Forbes
Wed, 06/7/23 - 09:34 pm
Tags:
Alzheimer's disease
,
FDA
,
insurance
,
Leqembia
,
Biogen
,
Eisai
,
Eli Lilly
,
donanemab
FDA Removes Expert with Ties to Eisai, Biogen from Leqembi Adcomm
BioSpace
Tue, 06/6/23 - 10:17 am
Tags:
FDA
,
Biogen
,
Eisai
,
Alzheimer's disease
,
Leqembi
PhRMA cries foul on CMS' registry approach for Alzheimer's disease drugs
Fierce Pharma
Sun, 06/4/23 - 04:15 pm
Tags:
Biogen
,
Eisai
,
Alzheimer's disease Leqembi
,
CMS
,
PhRMA
Medicare outlines plan to expand coverage for costly new Alzheimer’s drugs
Washington Post, DC
Fri, 06/2/23 - 10:18 am
Tags:
Medicare
,
Alzheimer's disease
,
Eisai
,
Biogen
,
Leqembi
The Alzheimer's pipeline is as strong as ever. Now, we just need the patients
Fierce Biotech
Wed, 05/31/23 - 07:02 pm
Tags:
Alzheimer's disease
,
patients
,
clinical trials
,
Biogen
,
Eisai
,
Eli Lilly
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
Merck and Eisai tease results for renal carcinoma treatment
Clinical Trials Arena
Tue, 05/30/23 - 09:18 pm
Tags:
Merck
,
Eisai
,
ASCO 2023
,
Lenvima
,
Keytruda
,
renal cell carcinoma
Amyloid-Beta Structure Revelation Sheds Light on Leqembi’s Function
BioSpace
Wed, 05/24/23 - 06:51 pm
Tags:
Eisai
,
Biogen
,
Alzheimer's disease
,
Leqembi
,
amyloid beta
JAMA: Leqembi could cost Medicare up to $5B per year
Medical Marketing and Media
Mon, 05/15/23 - 06:20 pm
Tags:
Biogen
,
Eisai
,
Leqembi
,
drug pricing
,
Medicare
,
Alzheimer's disease
,
JAMA
Eisai Pays up to $2B for ADC Bearing Its Halaven as Payload
BioSpace
Tue, 05/9/23 - 11:07 am
Tags:
Eisai
,
Bliss Biopharmaceutical
,
clinical trials
,
antibody-drug conjugate
,
Halaven
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
BioSpace
Fri, 04/7/23 - 01:58 pm
Tags:
Merck
,
Keytruda
,
Eisai
,
Lenvima
,
melanoma
,
clinical trials
,
cancer
,
colorectal cancer
Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO
Fierce Pharma
Tue, 03/21/23 - 09:58 pm
Tags:
Eisai
,
Leqembi
,
FDA
,
CMS
,
Alzheimer's disease
Alzheimer's Association campaigns for broader Leqembi coverage: report
Fierce Pharma
Fri, 03/17/23 - 11:43 am
Tags:
CMS
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
VA to cover Eisai's new Alzheimer's drug after declining to cover Aduhelm
Endpoints
Mon, 03/13/23 - 04:44 pm
Tags:
VHA
,
Eisai
,
Biogen
,
Leqembi
,
Aduhelm
,
Alzheimer's disease
Eisai projects $7B in sales by 2030 for new Alzheimer's drug
Endpoints
Sun, 03/12/23 - 09:40 pm
Tags:
Eisai
,
Biogen
,
Alzheimer's disease
,
Leqembi
FDA sets July decision date for full approval of Leqembi
BioSpace
Mon, 03/6/23 - 12:11 pm
Tags:
Eisai
,
Biogen
,
Alzheimer's disease
,
Leqembi
,
FDA
,
lecanemab
ICER dials up recommended price range for Eisai's Leqembi—but still calls for sizable discount
Fierce Pharma
Wed, 03/1/23 - 06:55 pm
Tags:
ICER
,
Eisai
,
Leqembi
,
drug pricing
,
Alzheimer's disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.